A 90-day dietary study on kappa carrageenan with emphasis on the gastrointestinal tract
Abstract
Groups of Fischer 344 rats (20/sex/group) received control or treated diets at levels of 0, 25,000 or 50,000 ppm kappa carrageenan with a molecular weight range (Mw) of 196,000-257,000 Da for 90 days. The Low Molecular Weight Tail (LMT) ranged between 1.9% and 12.0%<50 kDa (mean 7%) based on the results of a program initiated to develop a validated analytical method to measure the LMT. This is the first GLP dietary study in which carrageenan is characterized by percentage LMT. Clinical examinations were performed daily. Individual food consumption/body weight measurements were made weekly. Ophthalmic exam was conducted prior to and at the end of treatment. Hematology/serum chemistry and urinalysis evaluations were done at necropsy, as were organ weight determinations for adrenals, brain, heart, kidneys, liver, ovaries, spleen, testes and thyroid with parathyroids. Full histopathological evaluation of organs was conducted on the control and 50,000 ppm groups, including hematoxylin-eosin-stained cross sections of paraffin-embedded rolled colon. Clinical signs were limited to soft feces in high dose rats and to a lesser extent in low dose rats. There were no treatment-related effects on body weights, urinalysis, hematology or clinical chemistry parameters, or on organ weights or ophthalmic, macroscopic or microscopic findings. The gastrointestinal tract appeared normal in detailed histopathological evaluation using the Swiss roll technique. The NOAEL is 50,000 ppm in the diet (mean calculated test material consumption of 3394+/-706 mg/kg/day in males, 3867+/-647 mg/kg/day in females). The results of the study provide evidence that it is not necessary to characterize carrageenan by a specification for LMT (less than 5% below 50 kDa) as has been done in Commission Directive 2004/45/EC of 16 April 2004 (Commission Directive, 2004/45/EC of 16 April 2004 amending Directive 96/77/EC laying down specific purity criteria on food additives other than colors and sweeteners. Official Journal of European Union 20 April, 2004, L113/19-L113/21).
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Peroral application of κ-carrageenan is safe as concluded from a 90-day dietary study in rats.
“Similar conclusion about the safety of peroral application of κ-carrageenan was made as a result of a 90-day dietary study in rats [102].”
From Anticancer and Cancer Preventive Properties of Marine Polysaccharides: Some Results and Prospects (2013) · cites this paper as [102]
The citation lists haven’t been fetched yet
References 19 · Cited by 58
- Authors
- Weiner, M. L., Nuber, D., Blakemore, W. R., Harriman, J. F., & Cohen, S. M.
- Affiliations
- FMC (United States) (US)
- University of Nebraska Medical Center (US)
- Corresponding author
- Weiner, Myra L.
- Venue
- Food and Chemical Toxicology
- Publisher
- Elsevier BV
- Published
- 2007-01
- Volume
- 45
- Issue
- 1
- Pages
- 98-106
- ISSN
- 0278-6915 (ISSN-L)
- OpenAlex
- W2030621772
- Cited by
- 58
- References
- 19
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 6 · 2023: 3 · 2022: 3 · 2021: 7 · 2020: 3 · 2019: 5 · 2018: 4 · 2017: 2 · 2016: 2 · 2015: 3 · 2014: 6 · 2013: 5
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Food and Chemical Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Polysaccharides Composition and Applications
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Keywords
- kappa-carrageenan, dietary toxicity, gastrointestinal tract, no-observed-adverse-effect level, food additive safety, molecular weight characterization, histopathology, F344 rats, colon histology
- MeSH terms
- Administration, Oral, Animals, Body Weight, Carrageenan, Diarrhea, Diet, Dose-Response Relationship, Drug, Eating, European Union, Female, Food Additives, Hematologic Tests, Histological Techniques, Male, Molecular Weight, Organ Size, Rats, Inbred F344, No-Observed-Adverse-Effect Level, Clinical Chemistry Tests, Gastrointestinal Tract, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review